434 related articles for article (PubMed ID: 34234672)
1. FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics.
Liu Y; Deng J; Liu Y; Li W; Nie X
Front Pharmacol; 2021; 12():675725. PubMed ID: 34234672
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
4. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
5. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
[TBL] [Abstract][Full Text] [Related]
6. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
7. Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c.
Ohmachi S; Mikami T; Konishi M; Miyake A; Itoh N
J Neurosci Res; 2003 May; 72(4):436-43. PubMed ID: 12704805
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
9. Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.
Airavaara M; Parkkinen I; Konovalova J; Albert K; Chmielarz P; Domanskyi A
Curr Protoc Neurosci; 2020 Mar; 91(1):e88. PubMed ID: 32049438
[TBL] [Abstract][Full Text] [Related]
10. The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
MacMahon Copas AN; McComish SF; Fletcher JM; Caldwell MA
Front Neurol; 2021; 12():666737. PubMed ID: 34122308
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
12. Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation.
Belloli S; Morari M; Murtaj V; Valtorta S; Moresco RM; Gilardi MC
Front Aging Neurosci; 2020; 12():152. PubMed ID: 32581765
[TBL] [Abstract][Full Text] [Related]
13. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
Kuter K; Olech Ł; Głowacka U
Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation in Parkinson's disease and its potential as therapeutic target.
Wang Q; Liu Y; Zhou J
Transl Neurodegener; 2015; 4():19. PubMed ID: 26464797
[TBL] [Abstract][Full Text] [Related]
15. Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?
Navarro-Zaragoza J; Cuenca-Bermejo L; Almela P; Laorden ML; Herrero MT
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809767
[TBL] [Abstract][Full Text] [Related]
16. Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.
Masilamoni GJ; Smith Y
J Neural Transm (Vienna); 2018 Mar; 125(3):337-363. PubMed ID: 28861737
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
18. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
19. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
